Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptationBastiaan J. Viergever(University Medical Center Utrecht), Richard P. Meijer(Unknown)British Journal of CancerDecember 15, 202310.1038/s41416-023-02494-6Cited by 27SaveCiteExport RISWatch citationsRelated PapersEuropean Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines|European Urology|2023|618European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines|European Urology|2025|159Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”|European Urology|2020|132